Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.
In this Webinar we discuss:
Learn about the range of T cell states across cancer types.
Discover the biomarkers for identifying precise clinical CD8+T cell states.
Explore guiding clinical application and tailoring immunotherapy to patient immune function.